• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无症状小剂量阿司匹林服用者的内镜检查

Endoscopy in asymptomatic minidose aspirin consumers.

作者信息

Niv Yaron, Battler Alex, Abuksis Galia, Gal Eyal, Sapoznikov Boris, Vilkin Alex

机构信息

Department of Gastroenterology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel.

出版信息

Dig Dis Sci. 2005 Jan;50(1):78-80. doi: 10.1007/s10620-005-1281-1.

DOI:10.1007/s10620-005-1281-1
PMID:15712641
Abstract

Aspirin is widely used for its antiplatelet activity, but it harbors a risk of severe adverse gastrointestinal effects, such as bleeding and perforation, especially in elderly people. Our aim to assess the prevalence of upper gastrointestinal lesions and the effect of aspirin on the gastrointestinal mucosa in asymptomatic subjects taking minidose aspirin (100 to 325 mg per day) for more than 3 months. A prospective, open design was used. Patients attending the ophthalmology and cardiology outpatient clinics who had a medical history of more than 3 months of regular aspirin consumption were referred for esophagogastroduodenoscopy (EGD). Of the 90 patients referred for EGD, 44 were symptomatic (epigastric pain or dyspepsia) and were excluded from the study. The 46 asymptomatic patients included 22 men and 24 women of mean age 70 +/- 10 years (range, 36 to 87 years); 32% were current or former smokers. Mean daily aspirin dose was 129.34 +/- 76.61 mg. Only 24% were taking a gastroprotective agent. EGD revealed ulcer or erosions in 47.83% of the patients: erosive gastroduodenitis in 13 patients, gastric ulcer in 14, duodenal ulcer in 2, and gastric and duodenal ulcers in 2. Urease test for Helicobacter pylori infection was positive in 26%. Univariate and multivariate analysis revealed no factor other than aspirin predictive of a positive endoscopy. Minidose aspirin treatment is associated with a high prevalence of ulcerations of the stomach and duodenum.

摘要

阿司匹林因其抗血小板活性而被广泛使用,但它存在严重胃肠道不良反应的风险,如出血和穿孔,尤其是在老年人中。我们的目的是评估服用小剂量阿司匹林(每天100至325毫克)超过3个月的无症状受试者上消化道病变的患病率以及阿司匹林对胃肠道黏膜的影响。采用前瞻性开放设计。有超过3个月定期服用阿司匹林病史的眼科和心脏病科门诊患者被转诊进行食管胃十二指肠镜检查(EGD)。在转诊进行EGD的90名患者中,44名有症状(上腹部疼痛或消化不良),被排除在研究之外。46名无症状患者包括22名男性和24名女性,平均年龄70±10岁(范围36至87岁);32%为当前或既往吸烟者。平均每日阿司匹林剂量为129.34±76.61毫克。只有24%的患者正在服用胃保护剂。EGD显示47.83%的患者有溃疡或糜烂:13例为糜烂性胃十二指肠炎症,14例为胃溃疡,2例为十二指肠溃疡,2例为胃和十二指肠溃疡。幽门螺杆菌感染的尿素酶试验阳性率为26%。单因素和多因素分析显示,除阿司匹林外,没有其他因素可预测内镜检查结果为阳性。小剂量阿司匹林治疗与胃和十二指肠溃疡的高患病率相关。

相似文献

1
Endoscopy in asymptomatic minidose aspirin consumers.无症状小剂量阿司匹林服用者的内镜检查
Dig Dis Sci. 2005 Jan;50(1):78-80. doi: 10.1007/s10620-005-1281-1.
2
Investigation of gastroduodenal mucosal injuries caused by low-dose aspirin therapy in patients with cerebral infarction.探讨脑梗死患者低剂量阿司匹林治疗引起的胃十二指肠黏膜损伤。
J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S119-21. doi: 10.1111/j.1440-1746.2010.06229.x.
3
Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.低剂量阿司匹林相关胃十二指肠黏膜损伤的地域差异。
World J Gastroenterol. 2015 Jul 7;21(25):7709-17. doi: 10.3748/wjg.v21.i25.7709.
4
Predictors of gastroduodenal erosions in patients taking low-dose aspirin.服用低剂量阿司匹林患者的胃十二指肠黏膜损伤的预测因子。
Aliment Pharmacol Ther. 2010 Jan;31(1):143-9. doi: 10.1111/j.1365-2036.2009.04133.x.
5
[Endoscopic changes in the stomach and duodenal mucosa caused by minidose acetylsalicylic acid therapy and their prevention].
Vnitr Lek. 2007 Oct;53(10):1053-6.
6
Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.接受非甾体抗炎药加小剂量阿司匹林治疗的高危患者溃疡复发情况:一项事后分析的结果
Clin Ther. 2004 Oct;26(10):1637-43. doi: 10.1016/j.clinthera.2004.10.002.
7
[The epidemiology of the gastroduodenal damage induced by aspirin and other nonsteroidal anti-inflammatory drugs].[阿司匹林及其他非甾体抗炎药所致胃十二指肠损伤的流行病学]
Recenti Prog Med. 1997 May;88(5):202-11.
8
[Digestive and hemorrhage complications of low-dose aspirin].[小剂量阿司匹林的消化及出血并发症]
Presse Med. 2003 Nov 22;32(37 Pt 2):S17-28.
9
The prevalence of gastroduodenal mucosal injuries in aspirin users.阿司匹林使用者胃十二指肠黏膜损伤的患病率。
J Med Assoc Thai. 2013 Nov;96(11):1423-7.
10
Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.阿司匹林在心血管二级预防中的应用以及阿司匹林相关性糜烂和溃疡的发生
J Cardiovasc Pharmacol. 2016 Aug;68(2):121-6. doi: 10.1097/FJC.0000000000000387.

引用本文的文献

1
Adverse event profile of lorazepam: a real-world pharmacovigilance study using the FDA adverse event reporting system database.劳拉西泮的不良事件概况:一项使用美国食品药品监督管理局不良事件报告系统数据库的真实世界药物警戒研究。
Front Pharmacol. 2024 Nov 22;15:1465245. doi: 10.3389/fphar.2024.1465245. eCollection 2024.
2
Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation.新型磷脂阿司匹林制剂的药代动力学和药效学特征。
Clin Pharmacokinet. 2022 Apr;61(4):465-479. doi: 10.1007/s40262-021-01090-2. Epub 2022 Jan 20.
3
Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity.

本文引用的文献

1
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.罗非昔布与萘普生对类风湿关节炎患者上消化道毒性的比较。VIGOR研究组。
N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 1528. doi: 10.1056/NEJM200011233432103.
2
Time course inhibition of gastric and platelet COX activity by acetylsalicylic acid in humans.
Am J Physiol Gastrointest Liver Physiol. 2000 Nov;279(5):G1113-20. doi: 10.1152/ajpgi.2000.279.5.G1113.
3
Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding.硝酸血管扩张剂、小剂量阿司匹林、其他非甾体抗炎药与上消化道出血风险
非甾体抗炎药引起的上消化道毒性的药物基因组学
Front Pharmacol. 2021 Jun 21;12:684162. doi: 10.3389/fphar.2021.684162. eCollection 2021.
4
Screening for Gastric and Small Intestinal Mucosal Injury with Magnetically Controlled Capsule Endoscopy in Asymptomatic Patients Taking Enteric-Coated Aspirin.在服用肠溶阿司匹林的无症状患者中,使用磁控胶囊内镜筛查胃和小肠黏膜损伤
Gastroenterol Res Pract. 2018 Nov 15;2018:2524698. doi: 10.1155/2018/2524698. eCollection 2018.
5
The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis.马来酸伊索拉定治疗非甾体抗炎药或阿司匹林所致的消化性溃疡和胃炎的疗效和安全性。
Korean J Intern Med. 2019 Sep;34(5):1008-1021. doi: 10.3904/kjim.2017.370. Epub 2018 Jun 1.
6
Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.低剂量阿司匹林相关胃十二指肠黏膜损伤的地域差异。
World J Gastroenterol. 2015 Jul 7;21(25):7709-17. doi: 10.3748/wjg.v21.i25.7709.
7
Investigation of Gastroduodenal Mucosal Injury in Japanese Asymptomatic Antiplatelet Drug Users.日本无症状抗血小板药物使用者胃十二指肠黏膜损伤的调查
Medicine (Baltimore). 2015 Jul;94(26):e1047. doi: 10.1097/MD.0000000000001047.
8
Upper gastrointestinal mucosal injury and symptoms in elderly low-dose aspirin users.老年人低剂量阿司匹林使用者的上消化道黏膜损伤和症状。
Gastroenterol Res Pract. 2015;2015:252963. doi: 10.1155/2015/252963. Epub 2015 Jan 26.
9
Qing Dai attenuates nonsteroidal anti-inflammatory drug-induced mitochondrial reactive oxygen species in gastrointestinal epithelial cells.清黛减轻非甾体抗炎药诱导的胃肠道上皮细胞线粒体活性氧。
J Clin Biochem Nutr. 2015 Jan;56(1):8-14. doi: 10.3164/jcbn.14-59. Epub 2014 Nov 1.
10
Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment.胃肠道溃疡、阿司匹林的作用及临床结局:病理生物学、诊断与治疗
J Multidiscip Healthc. 2014 Mar 3;7:137-46. doi: 10.2147/JMDH.S54324. eCollection 2014.
N Engl J Med. 2000 Sep 21;343(12):834-9. doi: 10.1056/NEJM200009213431202.
4
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.塞来昔布与非甾体抗炎药治疗骨关节炎和类风湿关节炎的胃肠道毒性:CLASS研究:一项随机对照试验。塞来昔布长期关节炎安全性研究。
JAMA. 2000 Sep 13;284(10):1247-55. doi: 10.1001/jama.284.10.1247.
5
Epidemiology of NSAID induced gastrointestinal complications.非甾体抗炎药引起的胃肠道并发症的流行病学
J Rheumatol Suppl. 1999 Apr;56:18-24.
6
NSAID induced gastrointestinal complications: the ARAMIS perspective--1997. Arthritis, Rheumatism, and Aging Medical Information System.非甾体抗炎药引起的胃肠道并发症:ARAMIS研究视角——1997年。关节炎、风湿病与衰老医学信息系统。
J Rheumatol Suppl. 1998 May;51:8-16.
7
Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.奥美拉唑与米索前列醇治疗非甾体抗炎药相关性溃疡的比较。奥美拉唑与米索前列醇治疗非甾体抗炎药所致溃疡的研究组(OMNIUM研究组)。
N Engl J Med. 1998 Mar 12;338(11):727-34. doi: 10.1056/NEJM199803123381105.
8
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.奥美拉唑与雷尼替丁治疗非甾体抗炎药相关性溃疡的比较。抑酸试验:雷尼替丁与奥美拉唑治疗非甾体抗炎药相关性溃疡的研究(ASTRONAUT)研究组。
N Engl J Med. 1998 Mar 12;338(11):719-26. doi: 10.1056/NEJM199803123381104.
9
Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.肠溶包衣或缓冲剂型阿司匹林相关的严重上消化道出血风险。
Lancet. 1996 Nov 23;348(9039):1413-6. doi: 10.1016/S0140-6736(96)01254-8.
10
Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.与个体非甾体抗炎药相关的上消化道出血和穿孔风险。
Lancet. 1994 Mar 26;343(8900):769-72. doi: 10.1016/s0140-6736(94)91843-0.